Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

June 30, 2026

Conditions
Breast CancerTriple Negative Breast Cancer
Interventions
PROCEDURE

Biopsy

Patients undergo a biopsy from a lesion, and give 40ml of blood

Trial Locations (3)

W6 8RF

NOT_YET_RECRUITING

Imperial College Healthcare NHS Trust, London

Unknown

RECRUITING

Barts Hospital NHS Trust, London

NOT_YET_RECRUITING

Guys and St. Thomas Hospital NHS Trust, London

All Listed Sponsors
collaborator

Guys' and St. Thomas Hospital

UNKNOWN

collaborator

Barts & The London NHS Trust

OTHER

collaborator

Imperial College Healthcare NHS Trust

OTHER

collaborator

Nottingham University Hospitals Trust

UNKNOWN

collaborator

Hampshire Hospitals NHS Foundation Trust

OTHER

lead

Ourotech, Inc.

INDUSTRY